Latest advances in aging research and drug discovery.
View / Open Files
Authors
Bakula, Daniela
Ablasser, Andrea
Aguzzi, Adriano
Antebi, Adam
Barzilai, Nir
Bittner, Martin-Immanuel
Jensen, Martin Borch
Calkhoven, Cornelis F
Chen, Danica
Grey, Aubrey DNJ de
Feige, Jerome N
Georgievskaya, Anastasia
Gladyshev, Vadim N
Golato, Tyler
Gudkov, Andrei V
Kaeberlein, Matt
Katajisto, Pekka
Kennedy, Brian K
Lal, Unmesh
Martin-Villalba, Ana
Ozerov, Ivan
Petr, Michael A
Reason,
Tyshkovskiy, Alexander
Vanhaelen, Quentin
Zhavoronkov, Alex
Publication Date
2019-11-21Journal Title
Aging
ISSN
1945-4589
Volume
11
Issue
22
Pages
9971-9981
Language
eng
Type
Article
This Version
AM
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Bakula, D., Ablasser, A., Aguzzi, A., Antebi, A., Barzilai, N., Bittner, M., Jensen, M. B., et al. (2019). Latest advances in aging research and drug discovery.. Aging, 11 (22), 9971-9981. https://doi.org/10.18632/aging.102487
Abstract
An increasing aging population poses a significant challenge to societies worldwide. A better understanding of the molecular, cellular, organ, tissue, physiological, psychological, and even sociological changes that occur with aging is needed in order to treat age-associated diseases. The field of aging research is rapidly expanding with multiple advances transpiring in many previously disconnected areas. Several major pharmaceutical, biotechnology, and consumer companies made aging research a priority and are building internal expertise, integrating aging research into traditional business models and exploring new go-to-market strategies. Many of these efforts are spearheaded by the latest advances in artificial intelligence, namely deep learning, including generative and reinforcement learning. To facilitate these trends, the Center for Healthy Aging at the University of Copenhagen and Insilico Medicine are building a community of Key Opinion Leaders (KOLs) in these areas and launched the annual conference series titled “Aging Research and Drug Discovery (ARDD)” held in the capital of the pharmaceutical industry, Basel, Switzerland (www.agingpharma.org). This ARDD collection contains summaries from the 6th annual meeting that explored aging mechanisms and new interventions in age-associated diseases. The 7th annual ARDD exhibition will transpire 2nd-4th of September, 2020, in Basel.
Keywords
Humans, Aging, Research, Drug Industry, Drug Discovery
Embargo Lift Date
2022-11-13
Identifiers
External DOI: https://doi.org/10.18632/aging.102487
This record's URL: https://www.repository.cam.ac.uk/handle/1810/298873
Rights
All rights reserved